INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,509,000 | -89.9% | 202,000 | -82.5% | 0.08% | -87.8% |
| Q2 2019 | $14,941,000 | -18.4% | 1,152,900 | -23.3% | 0.62% | -7.7% |
| Q1 2019 | $18,308,000 | -27.9% | 1,503,100 | -32.6% | 0.67% | -61.3% |
| Q4 2018 | $25,383,000 | -11.9% | 2,228,500 | +67.8% | 1.74% | +22.1% |
| Q3 2018 | $28,824,000 | +40.8% | 1,328,300 | +14.6% | 1.42% | -7.6% |
| Q2 2018 | $20,473,000 | -4.7% | 1,159,300 | +13.5% | 1.54% | -20.4% |
| Q1 2018 | $21,492,000 | +251.2% | 1,021,000 | +141.5% | 1.94% | +336.5% |
| Q4 2017 | $6,120,000 | – | 422,700 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |